Drug Shortage Report for CYANOCOBALAMIN INJECTION USP

Last updated on 2023-12-15 History
Report ID 200983
Drug Identification Number 02463393
Brand name CYANOCOBALAMIN INJECTION USP
Common or Proper name CYANOCOBALAMIN INJECTION USP
Company Name HIKMA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) VITAMIN B12
Strength(s) 1000MCG
Dosage form(s) SOLUTION LIQUID
Route of administration SUBCUTANEOUS INTRAMUSCULAR SUBCUTANEOUS INTRAMUSCULAR
Packaging size 1mL
ATC code B03BA
ATC description VITAMIN B12 AND FOLIC ACID
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2023-09-01
Actual start date
Estimated end date 2023-11-30
Actual end date 2023-12-14
Shortage status Resolved
Updated date 2023-12-15
Company comments Product on allocation at distributors.
Health Canada comments
Tier 3 Status No
Contact Address 5995 AVEBURY ROAD, SUITE 804
MISSISSAUGA, ONTARIO
CANADA L5R 3P9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2023-12-15 French Compare
v4 2023-12-15 English Compare
v3 2023-09-02 English Compare
v2 2023-08-03 French Compare
v1 2023-08-03 English Compare

Showing 1 to 5 of 5